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Experimental Section 
CB6, CB7, CB8,  N,N'-Bis-(2-azido-ethyl)-dodecane-1,12-diamine.2HCl, were prepared according to literature. 
[5b, 6d, 7] All other reagents and solvents were of the commercial reagent grade and used without further 
purification except where noted. Nuclear Magnetic Resonance (NMR) spectra were recorded on Bruker Avance 
DPX-400 MHz spectrometer. In all cases, samples were dissolved in D2O with DSS (3-(trimethylsilyl)-1-
propanesulfonic acid sodium salt) as an external standard. Mass spectra were taken on Applied Biosystems 
MALDI-TOF MS mass spectrometer equipped with a YAG-Laser (? =335 nm) at 10-7 Torr and delayed 
extraction mode (delay 300 ns) by changing the laser intensity, if necessary. All spectra were acquired in 
reflector mode using 20 kV acceleration potential and they were the average of 60 laser shots. Then, data were 
transferred to a personal computer for further processing. 2,4,6- Trihydroxyacetophenone (THAP) was chosen as 
the MALDI matrix. 
Synthesis of N,N'-Bis-[1-(2-amino-ethyl)-1H-[1,2,3]triazol-4-ylmethyl]-dodecane-1,12-diamine: N,N'-Bis-
(2-azido-ethyl)-dodecane-1,12-diamine.2HCl (150 mg, 0.36 mmol), propargylamine.HCl (83 mg, 0.91 mmol) 
were dissolved in an ethanol-water mixture (5 ml, 2:3, v/v). Subsequently CuSO4.5H20 (4.5 mg, 0.015 mmol) 
and sodium ascorbate (7.5 mg, 0.036 mmol) were added. After stirring at rt overnight, the mixture was poured 
into water (5 ml) and 1M NaOH solution (2 ml) was added. It was stirred for 30 min and extracted with 
chloroform. Organic phase was collected and the solvent was removed under reduced pressure. The remaining 
solid residue was suspended in water and stirred further 30 min. White precipitates were collected by filtration 
and dried under high vacuum 3h. (170 mg, 92%). M.p. 122-123 °C; Elemental Analysis calcd (%) for C22H44N10 
C, 58,90; H, 9,89; N, 31,22; found: C, 58,63; H, 10.01; N, 31.07 
1H NMR (400 MHz, CDCl3, 25 °C): d 1.18 (m, 8H, F,G,H), 1.38 (m, 2H, E), 1.51 (m, 6H, -NH), 2.54 (t, 
2H,3JHH = 7.2 Hz, D), 3.03 (t, 2H, 3JHH = 5.9 Hz, A), 3.92 (s, 2H, C), 4.37 (t, 2H, 3JHH = 5.9 Hz, B), 7.47 (s, 1H, 
T); 13C NMR (100 MHz, D2O, 25 °C): d27.4, 29.6, 29.7, 30.2, 37.7, 49.6, 49.7, 50.4, 122.8 (triazole, = CH), 
148.8 (triazole, = CR).   
Hydrochloride salt of the ditriazole Axle A compound was prepared by dissolving it in diluted HCl solution. 
After stirring overnight at rt, the solvent was removed under reduced pressure and the solid residue was washed 
with THF. It was dried under high vacuum 5h. (180 mg, 95%). 
1H NMR (400 MHz, CDCl3, 25 °C): d 1.30 (m, 8H, F,G,H), 1.65 (m, 2H, E), 3.05 (t, 2H,3JHH = 7.2 Hz, D), 3.56 
(t, 2H, 3JHH = 5.9 Hz, A), 4.35 (s, 2H, C), 4.85 (t, 2H, 3JHH = 5.9 Hz, B), 8.12 (s, 1H, T); 
 
 
 
 
 
 
 
 
 
 
S4 
 
 
NMR and MALDI-MS Spectra 
 
 
 
 
 
 
Figure S1. 1H NMR (400 MHz, D2O, 25 °C) spectra of Axle A; the addition of (a) 0 equiv of CB6 (b) 0.5 equiv of CB6, (c) 1 
equiv of CB6, (d) 2.2 equiv of CB6 (* denotes impurities). 
 
 
Figure S2: Proposed structure of CB7-Axle A  and 1H NMR (400 MHz, D2O, 25 °C) spectra of Axle A; 
the addition of (a) 0 equiv of CB7 (b) 0.4 equiv of CB7, (c) 0.9 equiv of CB7, (c) 1.3 equiv of CB7. 
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Figure S3: Structure of CB8-Axle A  and 1H NMR (400 MHz, D2O, 25 °C) spectra of Axle A; the addition 
of (a) 0 equiv of CB8 (b) 0.5 equiv of CB8, (c) 1.2 equiv of CB8.  
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Figure S4: COSY-NMR spectrum Axle A. 
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Figure S5: COSY-NMR spectrum of [3]pseudorotaxane of CB8 with Axle A. 
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Figure S6: NOESY-NMR spectrum of [3]pseudorotaxane of CB8 with Axle A. 
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Figure S7: HMQC-NMR spectrum of [3]pseudorotaxane of CB8 with Axle A. 
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Figure S8: MALDI-mass spectrum of CB8-Axle A. 
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Figure S9: MALDI-mass spectrum of CB7-Axle A. 
 
Figure S10: MALDI-mass spectrum of Axle A+1CB8+2CB6. 
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Figure S11: The COSY-NMR spectra (400 MHz, 25 °C, D2O) of 96 h later after addition of 2 equiv CB6 
to Axle A+CB8. 
